{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:54:42Z","timestamp":1740164082292,"version":"3.37.3"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PRPCDEVTAU PID2021-123714OB-I00","PRPCDEVTAU PID2021-123714OB-I00","PRE2022-103197","PRPCDEVTAU PID2021-123714OB-I00","PRPCDEVTAU PID2021-123714OB-I00"],"award-info":[{"award-number":["PRPCDEVTAU PID2021-123714OB-I00","PRPCDEVTAU PID2021-123714OB-I00","PRE2022-103197","PRPCDEVTAU PID2021-123714OB-I00","PRPCDEVTAU PID2021-123714OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR2021-00453","SGR2021-00453","SGR2021-00453","SGR2021-00453"],"award-info":[{"award-number":["SGR2021-00453","SGR2021-00453","SGR2021-00453","SGR2021-00453"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010805","name":"Fundaci\u00f3n Tatiana P\u00e9rez de Guzm\u00e1n el Bueno","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007"],"award-info":[{"award-number":["LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007","LCF\/PR\/HR19\/52160007"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute of Neuroscience, University of Barcelona","award":["MDM-2017-0729"],"award-info":[{"award-number":["MDM-2017-0729"]}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72232-2","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:02:13Z","timestamp":1726506133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Julia","family":"Sala-Jarque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pol","family":"Andr\u00e9s-Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"Mart\u00ednez-Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pol","family":"Pic\u00f3n-Pag\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Nuvolone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Aguzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalina","family":"Gav\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"del R\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"72232_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359\u2013363. https:\/\/doi.org\/10.1038\/s41586-021-03911-7 (2021).","journal-title":"Nature"},{"key":"72232_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.neurol.2018.07.001","volume":"174","author":"GU Hoglinger","year":"2018","unstructured":"Hoglinger, G. U., Respondek, G. & Kovacs, G. G. New classification of tauopathies. Rev. Neurol. (Paris) 174, 664\u2013668. https:\/\/doi.org\/10.1016\/j.neurol.2018.07.001 (2018).","journal-title":"Rev. Neurol. (Paris)"},{"key":"72232_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-12-802395-2.00025-0","volume":"145","author":"GG Kovacs","year":"2017","unstructured":"Kovacs, G. G. Tauopathies. Handb. Clin. Neurol. 145, 355\u2013368. https:\/\/doi.org\/10.1016\/B978-0-12-802395-2.00025-0 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"72232_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-12679-1_1","volume":"215","author":"H Braak","year":"2015","unstructured":"Braak, H. & Del Tredici, K. Neuroanatomy and pathology of sporadic Alzheimer\u2019s disease. Adv. Anat. Embryol. Cell Biol. 215, 1\u2013162 (2015).","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"72232_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-32-9358-8_1","volume":"1184","author":"M Goedert","year":"2019","unstructured":"Goedert, M. & Spillantini, M. G. Ordered assembly of tau protein and neurodegeneration. Adv. Exp. Med. Biol. 1184, 3\u201321. https:\/\/doi.org\/10.1007\/978-981-32-9358-8_1 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"72232_CR6","first-page":"809","volume":"199","author":"C Duyckaerts","year":"2015","unstructured":"Duyckaerts, C. et al. Seeding and propagation of lesions in neurodegenerative diseases: A new paradigm. Bull. Acad. Natl. Med. 199, 809\u2013819 (2015).","journal-title":"Bull. Acad. Natl. Med."},{"key":"72232_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure, M. A. & Dickson, D. W. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 14, 32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5 (2019).","journal-title":"Mol. Neurodegener."},{"key":"72232_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ajp.23254","volume":"83","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten, A. F. T., Datta, D. & Preuss, T. M. Studies of aging nonhuman primates illuminate the etiology of early-stage Alzheimer\u2019s-like neuropathology: An evolutionary perspective. Am. J. Primatol. 83, e23254. https:\/\/doi.org\/10.1002\/ajp.23254 (2021).","journal-title":"Am. J. Primatol."},{"key":"72232_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0304-3940(87)90204-7","volume":"76","author":"H Braak","year":"1987","unstructured":"Braak, H. & Braak, E. Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci. Lett. 76, 124\u2013127. https:\/\/doi.org\/10.1016\/0304-3940(87)90204-7 (1987).","journal-title":"Neurosci. Lett."},{"key":"72232_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0072-9752(07)01251-1","volume":"89","author":"M Tolnay","year":"2008","unstructured":"Tolnay, M. & Probst, A. Argyrophilic grain disease. Handb. Clin. Neurol. 89, 553\u2013563. https:\/\/doi.org\/10.1016\/S0072-9752(07)01251-1 (2008).","journal-title":"Handb. Clin. Neurol."},{"key":"72232_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/brain\/awm305","volume":"131","author":"I Ferrer","year":"2008","unstructured":"Ferrer, I., Santpere, G. & van Leeuwen, F. W. Argyrophilic grain disease. Brain 131, 1416\u20131432. https:\/\/doi.org\/10.1093\/brain\/awm305 (2008).","journal-title":"Brain"},{"key":"72232_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer, I. et al. Glial and neuronal tau pathology in tauopathies: Characterization of disease-specific phenotypes and tau pathology progression. J. Neuropathol. Exp. Neurol. 73, 81\u201397. https:\/\/doi.org\/10.1097\/NEN.0000000000000030 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"72232_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary, J. F. et al. Primary age-related tauopathy (PART): A common pathology associated with human aging. Acta Neuropathol. 128, 755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0 (2014).","journal-title":"Acta Neuropathol."},{"key":"72232_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs, G. G. Invited review: Neuropathology of tauopathies: Principles and practice. Neuropathol. Appl. Neurobiol. 41, 3\u201323. https:\/\/doi.org\/10.1111\/nan.12208 (2015).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"72232_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs, G. G. et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 131, 87\u2013102. https:\/\/doi.org\/10.1007\/s00401-015-1509-x (2016).","journal-title":"Acta Neuropathol."},{"key":"72232_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/bpa.12593","volume":"28","author":"I Ferrer","year":"2018","unstructured":"Ferrer, I. et al. Aging-related tau astrogliopathy (ARTAG): Not only tau phosphorylation in astrocytes. Brain Pathol. 28, 965\u2013985. https:\/\/doi.org\/10.1111\/bpa.12593 (2018).","journal-title":"Brain Pathol."},{"key":"72232_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101644","volume":"180","author":"TW Rosler","year":"2019","unstructured":"Rosler, T. W. et al. Four-repeat tauopathies. Prog. Neurobiol. 180, 101644. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101644 (2019).","journal-title":"Prog. Neurobiol."},{"key":"72232_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Masuda-Suzukake, M. & Falcon, B. Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140, 266\u2013278. https:\/\/doi.org\/10.1093\/brain\/aww230 (2017).","journal-title":"Brain"},{"key":"72232_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","volume":"127","author":"Z Ahmed","year":"2014","unstructured":"Ahmed, Z. et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 127, 667\u2013683. https:\/\/doi.org\/10.1007\/s00401-014-1254-6 (2014).","journal-title":"Acta Neuropathol."},{"key":"72232_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell. Biol. 11, 909\u2013913. https:\/\/doi.org\/10.1038\/ncb1901 (2009).","journal-title":"Nat. Cell. Biol."},{"key":"72232_CR21","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera, F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl. Acad. Sci. USA 110, 9535\u20139540. https:\/\/doi.org\/10.1073\/pnas.1301175110 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72232_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda, S. et al. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains. Acta Neuropathol. 129, 221\u2013237. https:\/\/doi.org\/10.1007\/s00401-014-1373-0 (2015).","journal-title":"Acta Neuropathol."},{"key":"72232_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415940","author":"I Ferrer","year":"2022","unstructured":"Ferrer, I., Andres-Benito, P., Carmona, M. & Del Rio, J. A. Common and specific marks of different tau strains following intra-hippocampal injection of AD, PiD, and GGT inoculum in htau transgenic mice. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232415940 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"72232_CR24","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ajpath.2016.06.008","volume":"186","author":"E Audouard","year":"2016","unstructured":"Audouard, E. et al. High-molecular-weight paired helical filaments from alzheimer brain induces seeding of wild-type mouse tau into an argyrophilic 4r tau pathology in vivo. Am. J. Pathol. 186, 2709\u20132722. https:\/\/doi.org\/10.1016\/j.ajpath.2016.06.008 (2016).","journal-title":"Am. J. Pathol."},{"key":"72232_CR25","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo, J. L. et al. Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice. J. Exp. Med. 213, 2635\u20132654. https:\/\/doi.org\/10.1084\/jem.20160833 (2016).","journal-title":"J. Exp. Med."},{"key":"72232_CR26","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/JNEUROSCI.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan, S. et al. Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J. Neurosci. 37, 11406\u201311423. https:\/\/doi.org\/10.1523\/JNEUROSCI.1230-17.2017 (2017).","journal-title":"J. Neurosci."},{"key":"72232_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00401-019-02122-9","volume":"139","author":"I Ferrer","year":"2020","unstructured":"Ferrer, I. et al. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Acta Neuropathol. 139, 735\u2013771. https:\/\/doi.org\/10.1007\/s00401-019-02122-9 (2020).","journal-title":"Acta Neuropathol."},{"key":"72232_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fnmol.2020.00101","volume":"13","author":"I Ferrer","year":"2020","unstructured":"Ferrer, I., Andres-Benito, P., Sala-Jarque, J., Gil, V. & Del Rio, J. A. Capacity for seeding and spreading of argyrophilic grain disease in a wild-type murine model; comparisons with primary age-related tauopathy. Front. Mol. Neurosci. 13, 101. https:\/\/doi.org\/10.3389\/fnmol.2020.00101 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"72232_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/jnen\/nlaa086","volume":"79","author":"SA Weitzman","year":"2020","unstructured":"Weitzman, S. A. et al. Insoluble tau from human FTDP-17 cases exhibit unique transmission properties in vivo. J. Neuropathol. Exp. Neurol. 79, 941\u2013949. https:\/\/doi.org\/10.1093\/jnen\/nlaa086 (2020).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"72232_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020718","author":"P Andres-Benito","year":"2022","unstructured":"Andres-Benito, P. et al. Host tau genotype specifically designs and regulates tau seeding and spreading and host tau transformation following intrahippocampal injection of identical tau AD inoculum. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23020718 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"72232_CR31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/mds.28107","volume":"35","author":"M Stamelou","year":"2020","unstructured":"Stamelou, M. LRP1: a novel mediator of tau uptake. Mov. Disord. 35, 1136. https:\/\/doi.org\/10.1002\/mds.28107 (2020).","journal-title":"Mov. Disord."},{"key":"72232_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch, J. N. et al. LRP1 is a master regulator of tau uptake and spread. Nature 580, 381\u2013385. https:\/\/doi.org\/10.1038\/s41586-020-2156-5 (2020).","journal-title":"Nature"},{"key":"72232_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett, G. T. et al. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol. 139, 503\u2013526. https:\/\/doi.org\/10.1007\/s00401-019-02114-9 (2020).","journal-title":"Acta Neuropathol."},{"key":"72232_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/19336896.2020.1854034","volume":"14","author":"G Legname","year":"2020","unstructured":"Legname, G. & Scialo, C. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases. Prion 14, 257\u2013270. https:\/\/doi.org\/10.1080\/19336896.2020.1854034 (2020).","journal-title":"Prion"},{"key":"72232_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105054","author":"L Celauro","year":"2023","unstructured":"Celauro, L. et al. Different tau fibril types reduce prion level in chronically and de novo infected cells. J. Biol. Chem. https:\/\/doi.org\/10.1016\/j.jbc.2023.105054 (2023).","journal-title":"J. Biol. Chem."},{"key":"72232_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.16.541015","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. Pathological Tau transmission initiated by binding lymphocyte-activation gene 3. BioRxiv. https:\/\/doi.org\/10.1101\/2023.05.16.541015 (2023).","journal-title":"BioRxiv."},{"key":"72232_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303775","author":"C Chen","year":"2024","unstructured":"Chen, C. et al. Lymphocyte-activation gene 3 facilitates pathological tau neuron-to-neuron transmission. Adv. Sci. (Weinh). https:\/\/doi.org\/10.1002\/advs.202303775 (2024).","journal-title":"Adv. Sci. (Weinh)."},{"key":"72232_CR38","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/j.1471-4159.2007.04904.x","volume":"103","author":"FR Lima","year":"2007","unstructured":"Lima, F. R. et al. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J. Neurochem. 103, 2164\u20132176. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04904.x (2007).","journal-title":"J. Neurochem."},{"key":"72232_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0896-6273(95)90307-0","volume":"14","author":"M Moser","year":"1995","unstructured":"Moser, M., Colello, R. J., Pott, U. & Oesch, B. Developmental expression of the prion protein gene in glial cells. Neuron 14, 509\u2013517. https:\/\/doi.org\/10.1016\/0896-6273(95)90307-0 (1995).","journal-title":"Neuron"},{"key":"72232_CR40","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/01.jnen.0000228137.10531.72","volume":"65","author":"H Adle-Biassette","year":"2006","unstructured":"Adle-Biassette, H. et al. Immunohistochemical expression of prion protein (PrPC) in the human forebrain during development. J. Neuropathol. Exp. Neurol. 65, 698\u2013706. https:\/\/doi.org\/10.1097\/01.jnen.0000228137.10531.72 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"72232_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033872","volume":"7","author":"A Bribian","year":"2012","unstructured":"Bribian, A. et al. Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS. PLoS One 7, e33872. https:\/\/doi.org\/10.1371\/journal.pone.0033872 (2012).","journal-title":"PLoS One"},{"key":"72232_CR42","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128\u20131132. https:\/\/doi.org\/10.1038\/nature07761 (2009).","journal-title":"Nature"},{"key":"72232_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000332596","volume":"10","author":"UK Resenberger","year":"2012","unstructured":"Resenberger, U. K., Winklhofer, K. F. & Tatzelt, J. Cellular prion protein mediates toxic signaling of amyloid beta. Neurodegener. Dis. 10, 298\u2013300. https:\/\/doi.org\/10.1159\/000332596 (2012).","journal-title":"Neurodegener. Dis."},{"key":"72232_CR44","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/emboj.2011.86","volume":"30","author":"UK Resenberger","year":"2011","unstructured":"Resenberger, U. K. et al. The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057\u20132070. https:\/\/doi.org\/10.1038\/emboj.2011.86 (2011).","journal-title":"EMBO J."},{"key":"72232_CR45","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/cbic.201402377","volume":"15","author":"KA Ganzinger","year":"2014","unstructured":"Ganzinger, K. A. et al. Single-molecule imaging reveals that small amyloid-beta1-42 oligomers interact with the cellular prion protein (PrP(C)). Chembiochem 15, 2515\u20132521. https:\/\/doi.org\/10.1002\/cbic.201402377 (2014).","journal-title":"Chembiochem"},{"key":"72232_CR46","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira, D. G. et al. alpha-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B. Nat. Neurosci. 20, 1569\u20131579. https:\/\/doi.org\/10.1038\/nn.4648 (2017).","journal-title":"Nat. Neurosci."},{"key":"72232_CR47","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbrc.2016.09.062","volume":"483","author":"SV Salazar","year":"2017","unstructured":"Salazar, S. V. & Strittmatter, S. M. Cellular prion protein as a receptor for amyloid-beta oligomers in Alzheimer\u2019s disease. Biochem. Biophys. Res. Commun. 483, 1143\u20131147. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.062 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"72232_CR48","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s12035-017-0451-4","volume":"55","author":"L Urrea","year":"2018","unstructured":"Urrea, L. et al. Involvement of cellular prion protein in alpha-synuclein transport in neurons. Mol. Neurobiol. 55, 1847\u20131860. https:\/\/doi.org\/10.1007\/s12035-017-0451-4 (2018).","journal-title":"Mol. Neurobiol."},{"key":"72232_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fncel.2019.00339","volume":"13","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Cellular prion protein as a receptor of toxic amyloid-beta42 oligomers is important for Alzheimer\u2019s disease. Front. Cell Neurosci. 13, 339. https:\/\/doi.org\/10.3389\/fncel.2019.00339 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"72232_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/mds.28774","volume":"37","author":"T Thom","year":"2022","unstructured":"Thom, T. et al. Cellular prion protein mediates alpha-synuclein uptake, localization, and toxicity in vitro and in vivo. Mov. Disord. 37, 39\u201351. https:\/\/doi.org\/10.1002\/mds.28774 (2022).","journal-title":"Mov. Disord."},{"key":"72232_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pneurobio.2018.03.001","volume":"165\u2013167","author":"JA Del Rio","year":"2018","unstructured":"Del Rio, J. A., Ferrer, I. & Gavin, R. Role of cellular prion protein in interneuronal amyloid transmission. Prog. Neurobiol. 165\u2013167, 87\u2013102. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.03.001 (2018).","journal-title":"Prog. Neurobiol."},{"key":"72232_CR52","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","volume":"38","author":"T Ondrejcak","year":"2018","unstructured":"Ondrejcak, T. et al. Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo. J Neurosci 38, 10595\u201310606. https:\/\/doi.org\/10.1523\/JNEUROSCI.1700-18.2018 (2018).","journal-title":"J Neurosci"},{"key":"72232_CR53","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro, B. et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435\u20131439. https:\/\/doi.org\/10.1126\/science.1110837 (2005).","journal-title":"Science"},{"key":"72232_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.20151610","volume":"213","author":"M Nuvolone","year":"2016","unstructured":"Nuvolone, M. et al. Strictly co-isogenic C57BL\/6J-Prnp-\/- mice: A rigorous resource for prion science. J. Exp. Med. 213, 313\u2013327. https:\/\/doi.org\/10.1084\/jem.20151610 (2016).","journal-title":"J. Exp. Med."},{"key":"72232_CR55","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20222","volume":"150","author":"G Manni","year":"2020","unstructured":"Manni, G. et al. The cellular prion protein beyond prion diseases. Swiss. Med. Wkly. 150, w20222. https:\/\/doi.org\/10.4414\/smw.2020.20222 (2020).","journal-title":"Swiss. Med. Wkly."},{"key":"72232_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030591","author":"R Gavin","year":"2020","unstructured":"Gavin, R., Lidon, L., Ferrer, I. & Del Rio, J. A. The quest for cellular prion protein functions in the aged and neurodegenerating brain. Cells. https:\/\/doi.org\/10.3390\/cells9030591 (2020).","journal-title":"Cells."},{"key":"72232_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-017-1790-y","volume":"135","author":"JC Watts","year":"2018","unstructured":"Watts, J. C., Bourkas, M. E. C. & Arshad, H. The function of the cellular prion protein in health and disease. Acta Neuropathol. 135, 159\u2013178. https:\/\/doi.org\/10.1007\/s00401-017-1790-y (2018).","journal-title":"Acta Neuropathol."},{"key":"72232_CR58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/bs.pmbts.2020.08.008","volume":"175","author":"C Scialo","year":"2020","unstructured":"Scialo, C. & Legname, G. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates. Prog. Mol. Biol. Transl. Sci. 175, 297\u2013323. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.008 (2020).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"72232_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/v13081625","author":"C Scialo","year":"2021","unstructured":"Scialo, C. et al. The cellular prion protein increases the uptake and toxicity of TDP-43 fibrils. Viruses https:\/\/doi.org\/10.3390\/v13081625 (2021).","journal-title":"Viruses"},{"key":"72232_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnagi.2019.00112","volume":"11","author":"I Ferrer","year":"2019","unstructured":"Ferrer, I. et al. Involvement of oligodendrocytes in tau seeding and spreading in tauopathies. Front. Aging Neurosci. 11, 112. https:\/\/doi.org\/10.3389\/fnagi.2019.00112 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"72232_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-024-01392-0","volume":"16","author":"Z Jiang","year":"2024","unstructured":"Jiang, Z. et al. A nonhuman primate model with Alzheimer\u2019s disease-like pathology induced by hippocampal overexpression of human tau. Alzheimers Res. Ther. 16, 22. https:\/\/doi.org\/10.1186\/s13195-024-01392-0 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"72232_CR62","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/glia.23865","volume":"68","author":"M Villa Gonzalez","year":"2020","unstructured":"Villa Gonzalez, M. et al. Focal cerebral ischemia induces changes in oligodendrocytic tau isoforms in the damaged area. Glia 68, 2471\u20132485. https:\/\/doi.org\/10.1002\/glia.23865 (2020).","journal-title":"Glia"},{"key":"72232_CR63","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jcp.28988","volume":"235","author":"B He","year":"2020","unstructured":"He, B., Chen, W., Zeng, J., Tong, W. & Zheng, P. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer\u2019s disease. J. Cell Physiol. 235, 480\u2013493. https:\/\/doi.org\/10.1002\/jcp.28988 (2020).","journal-title":"J. Cell Physiol."},{"key":"72232_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116132","author":"A Robert","year":"2021","unstructured":"Robert, A., Scholl, M. & Vogels, T. Tau seeding mouse models with patient brain-derived aggregates. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22116132 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"72232_CR65","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awab289","volume":"145","author":"M Hosokawa","year":"2022","unstructured":"Hosokawa, M. et al. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms. Brain 145, 349\u2013361. https:\/\/doi.org\/10.1093\/brain\/awab289 (2022).","journal-title":"Brain"},{"key":"72232_CR66","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288. https:\/\/doi.org\/10.1016\/j.neuron.2014.04.047 (2014).","journal-title":"Neuron"},{"key":"72232_CR67","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/brain\/awab091","volume":"144","author":"A Tarutani","year":"2021","unstructured":"Tarutani, A. et al. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification. Brain 144, 2333\u20132348. https:\/\/doi.org\/10.1093\/brain\/awab091 (2021).","journal-title":"Brain"},{"key":"72232_CR68","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00415-021-10573-y","volume":"269","author":"Y Wei","year":"2022","unstructured":"Wei, Y., Liu, M. & Wang, D. The propagation mechanisms of extracellular tau in Alzheimer\u2019s disease. J. Neurol. 269, 1164\u20131181. https:\/\/doi.org\/10.1007\/s00415-021-10573-y (2022).","journal-title":"J. Neurol."},{"key":"72232_CR69","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.mcn.2004.09.006","volume":"28","author":"L Fioriti","year":"2005","unstructured":"Fioriti, L. et al. The neurotoxicity of prion protein (PrP) peptide 106\u2013126 is independent of the expression level of PrP and is not mediated by abnormal PrP species. Mol. Cell Neurosci. 28, 165\u2013176. https:\/\/doi.org\/10.1016\/j.mcn.2004.09.006 (2005).","journal-title":"Mol. Cell Neurosci."},{"key":"72232_CR70","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1016\/j.febslet.2005.06.037","volume":"579","author":"R Gavin","year":"2005","unstructured":"Gavin, R. et al. PrP(106\u2013126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc. FEBS Lett. 579, 4099\u20134106. https:\/\/doi.org\/10.1016\/j.febslet.2005.06.037 (2005).","journal-title":"FEBS Lett."},{"key":"72232_CR71","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.nbd.2016.03.001","volume":"91","author":"JJ Scott-McKean","year":"2016","unstructured":"Scott-McKean, J. J. et al. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Abeta oligomers: Implications for novel therapeutic strategy in Alzheimer\u2019s disease. Neurobiol. Dis. 91, 124\u2013131. https:\/\/doi.org\/10.1016\/j.nbd.2016.03.001 (2016).","journal-title":"Neurobiol. Dis."},{"key":"72232_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115817","volume":"261","author":"Z Li","year":"2023","unstructured":"Li, Z., Yin, B., Zhang, S., Lan, Z. & Zhang, L. Targeting protein kinases for the treatment of Alzheimer\u2019s disease: Recent progress and future perspectives. Eur. J. Med. Chem. 261, 115817. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115817 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"72232_CR73","doi-asserted-by":"publisher","first-page":"1003721","DOI":"10.3389\/fnagi.2022.1003721","volume":"14","author":"MI Holubiec","year":"2022","unstructured":"Holubiec, M. I., Gellert, M. & Hanschmann, E. M. Redox signaling and metabolism in Alzheimer\u2019s disease. Front. Aging Neurosci. 14, 1003721. https:\/\/doi.org\/10.3389\/fnagi.2022.1003721 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"72232_CR74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/awy318","volume":"142","author":"P La Vitola","year":"2019","unstructured":"La Vitola, P. et al. Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain 142, 249\u2013254. https:\/\/doi.org\/10.1093\/brain\/awy318 (2019).","journal-title":"Brain"},{"key":"72232_CR75","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1073\/pnas.0911829107","volume":"107","author":"C Balducci","year":"2010","unstructured":"Balducci, C. et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA 107, 2295\u20132300. https:\/\/doi.org\/10.1073\/pnas.0911829107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72232_CR76","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/emmm.201000082","volume":"2","author":"AM Calella","year":"2010","unstructured":"Calella, A. M. et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306\u2013314. https:\/\/doi.org\/10.1002\/emmm.201000082 (2010).","journal-title":"EMBO Mol. Med."},{"key":"72232_CR77","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1523\/JNEUROSCI.1459-11.2011","volume":"31","author":"M Cisse","year":"2011","unstructured":"Cisse, M. et al. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427\u201310431. https:\/\/doi.org\/10.1523\/JNEUROSCI.1459-11.2011 (2011).","journal-title":"J. Neurosci."},{"key":"72232_CR78","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/ncomms3416","volume":"4","author":"AJ Nicoll","year":"2013","unstructured":"Nicoll, A. J. et al. Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity. Nat. Commun. 4, 2416. https:\/\/doi.org\/10.1038\/ncomms3416 (2013).","journal-title":"Nat. Commun."},{"key":"72232_CR79","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","volume":"114","author":"HN Dawson","year":"2001","unstructured":"Dawson, H. N. et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell Sci. 114, 1179\u20131187. https:\/\/doi.org\/10.1242\/jcs.114.6.1179 (2001).","journal-title":"J. Cell Sci."},{"key":"72232_CR80","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","volume":"22","author":"B Allen","year":"2002","unstructured":"Allen, B. et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340\u20139351. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-21-09340.2002 (2002).","journal-title":"J. Neurosci."},{"key":"72232_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.010 (2007).","journal-title":"Neuron"},{"key":"72232_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gene.20046","volume":"40","author":"NL Tuzi","year":"2004","unstructured":"Tuzi, N. L. et al. Cre-loxP mediated control of PrP to study transmissible spongiform encephalopathy diseases. Genesis 40, 1\u20136. https:\/\/doi.org\/10.1002\/gene.20046 (2004).","journal-title":"Genesis"},{"key":"72232_CR83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/dvg.20226","volume":"44","author":"NC Dubois","year":"2006","unstructured":"Dubois, N. C., Hofmann, D., Kaloulis, K., Bishop, J. M. & Trumpp, A. Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre\/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues. Genesis 44, 355\u2013360. https:\/\/doi.org\/10.1002\/dvg.20226 (2006).","journal-title":"Genesis"},{"key":"72232_CR84","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Perciedu Sert","year":"2020","unstructured":"Perciedu Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 18, e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"PLoS Biol"},{"key":"72232_CR85","volume-title":"Encyclopedia of the neurological sciences","author":"MJ Aminoff","year":"2014","unstructured":"Aminoff, M. J. & Daroff, R. B. Encyclopedia of the neurological sciences (Academic Press\/Elsevier, 2014)."},{"key":"72232_CR86","volume-title":"Atlas of the human brain","author":"JRK Mai","year":"1997","unstructured":"Mai, J. R. K., Assheuer, J. & Paxinos, G. Atlas of the human brain (Academic Press, 1997)."},{"key":"72232_CR87","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(sici)1097-4547","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha, G. A., Bowser, R., Kazam, I. G. & Davies, P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128\u2013132. https:\/\/doi.org\/10.1002\/(sici)1097-4547 (1997).","journal-title":"J. Neurosci. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72232-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72232-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72232-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:09:07Z","timestamp":1726506547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72232-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72232"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72232-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21622"}}